mPhase Technologies receives U.S. patent for "greener" battery technology

mPhase Technologies, Inc. (OTCBB: XDSL) reported today that it has been granted a United States patent for its concept for a battery that is safer for the environment. mPhase's "greener" battery technology could potentially help to reduce the harmful residual chemicals in a battery once it has reached the end of its life and is discarded. This approach reduces the risk that potentially harmful chemicals will leak through the battery container and pollute the ground or air, after the battery has been disposed of.

The technique described in the patent is based on the idea of neutralizing the harmful chemistry inside the battery by dispensing a neutralizing agent or containment polymer that is located inside the battery fixture and dispensed once the battery is depleted. This process is an important step forward in creating safer, green batteries.

The use of this patented technique may be incorporated into future battery designs by battery vendors, and could be implemented in future designs of the mPhase Smart NanoBattery. The Smart NanoBattery is being developed as part of the U.S. Army STTR Program to develop unique new battery technology for military purposes. The reserve battery design uses electrowetting and microfluidic techniques to selectively activate and control the power generated by the cells in the reserve battery.

"This patent is a major step in creating new approaches for designing batteries that could be safer for the environment," said mPhase CEO Ron Durando. "This concept is not just something that can be implemented in our own products, but has applicability that could be incorporated by other vendors in the battery industry."

SOURCE: mPhase Technologies

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy